1. Home
  2. KORE vs ATNM Comparison

KORE vs ATNM Comparison

Compare KORE & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KORE
  • ATNM
  • Stock Information
  • Founded
  • KORE 2003
  • ATNM 2000
  • Country
  • KORE United States
  • ATNM United States
  • Employees
  • KORE N/A
  • ATNM N/A
  • Industry
  • KORE Telecommunications Equipment
  • ATNM Biotechnology: Pharmaceutical Preparations
  • Sector
  • KORE Consumer Discretionary
  • ATNM Health Care
  • Exchange
  • KORE Nasdaq
  • ATNM Nasdaq
  • Market Cap
  • KORE 44.4M
  • ATNM 46.5M
  • IPO Year
  • KORE N/A
  • ATNM N/A
  • Fundamental
  • Price
  • KORE $2.42
  • ATNM $1.21
  • Analyst Decision
  • KORE Hold
  • ATNM Strong Buy
  • Analyst Count
  • KORE 1
  • ATNM 4
  • Target Price
  • KORE $2.50
  • ATNM $8.75
  • AVG Volume (30 Days)
  • KORE 13.0K
  • ATNM 1.4M
  • Earning Date
  • KORE 05-14-2025
  • ATNM 04-29-2025
  • Dividend Yield
  • KORE N/A
  • ATNM N/A
  • EPS Growth
  • KORE N/A
  • ATNM N/A
  • EPS
  • KORE N/A
  • ATNM N/A
  • Revenue
  • KORE $285,229,000.00
  • ATNM N/A
  • Revenue This Year
  • KORE $3.89
  • ATNM N/A
  • Revenue Next Year
  • KORE $5.35
  • ATNM N/A
  • P/E Ratio
  • KORE N/A
  • ATNM N/A
  • Revenue Growth
  • KORE 7.01
  • ATNM N/A
  • 52 Week Low
  • KORE $1.10
  • ATNM $1.03
  • 52 Week High
  • KORE $4.88
  • ATNM $10.24
  • Technical
  • Relative Strength Index (RSI)
  • KORE 50.01
  • ATNM 43.76
  • Support Level
  • KORE $2.20
  • ATNM $1.18
  • Resistance Level
  • KORE $2.55
  • ATNM $1.34
  • Average True Range (ATR)
  • KORE 0.18
  • ATNM 0.15
  • MACD
  • KORE -0.00
  • ATNM -0.03
  • Stochastic Oscillator
  • KORE 62.75
  • ATNM 11.99

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: